Dawaa Reference

infectious

Common Cold (viral URTI, adult and child)

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources7 sources

Afrin 0.5 mg/ml nasal spray SmPC sections 4.1-4.3 - Dutch Medicines Evaluation Board (CBG-MEB), procedure NL/H/1971/001-004, Aug 2022 (afrin-oxymetazoline-smpc-cbg-nl-2022.txt): "Afrin 0,5 mg/ml neusspray, oplossing" and "Elke ml oplossing bevat 0,5 mg oxymetazolinehydrochloride", which is the 0.05% strength. · Ibuprofen 100 mg/5 ml SmPC section 4.2 (eMC product 4560) · Iliadin Nose Drops / Nose Spray 0.05% Professional Information - South African Health Products Regulatory Authority (English cross-check) · MHRA Drug Safety Update 30 April 2026 - nasal decongestants containing xylometazoline / oxymetazoline: rebound congestion with overuse · Paracetamol 500mg capsule shaped tablets SmPC section 4.2 (eMC product 12154) · Saline Nasal Spray (sodium chloride 0.65%) US OTC Drug Facts (DailyMed SetID ed30a7f9-7132-42da-9bed-63a9b1c80ab2) · StatPearls: Ibuprofen (NCBI Bookshelf NBK542299)

Verified against8 documents
  • Afrin 0.5 mg/ml nasal spray SmPC sections 4.1-4.3 - Dutch Medicines Evaluation Board (CBG-MEB), procedure NL/H/1971/001-004, Aug 2022 (afrin-oxymetazoline-smpc-cbg-nl-2022.txt): "Afrin 0,5 mg/ml neusspray, oplossing" and "Elke ml oplossing bevat 0,5 mg oxymetazolinehydrochloride", which is the 0.05% strength.
  • Ibuprofen 100 mg/5 ml SmPC section 4.2 (eMC product 4560)
  • Iliadin Nose Drops / Nose Spray 0.05% Professional Information - South African Health Products Regulatory Authority (English cross-check)
  • MHRA Drug Safety Update 30 April 2026 - nasal decongestants containing xylometazoline / oxymetazoline: rebound congestion with overuse
  • Paracetamol 500mg capsule shaped tablets SmPC section 4.2 (eMC product 12154)
  • Saline Nasal Spray (sodium chloride 0.65%) US OTC Drug Facts (DailyMed SetID ed30a7f9-7132-42da-9bed-63a9b1c80ab2)
  • Upper Respiratory Tract Infections With Focus on The Common Cold - disease-level clinical article (common-cold-clinical.txt)
  • MSF Essential Drugs 2024 - paracetamol (oral)

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (5)

  • Sore throat is usually the first symptom, followed one to two days later by a runny nose and sneezing [runny nose · sneezing · sore throat]
  • Nasal blockage, hoarseness, and cough tend to develop shortly after the sore throat and runny nose begin [blocked nose · cough · hoarseness · runny nose · sore throat]
  • Feeling unwell, low-grade fever, muscle aches, and headache are common early in the illness [fever · headache · malaise · muscle pain]
  • Illness usually resolves within 7 to 10 days, though the cough can drag on for several weeks [cough]
  • A runny nose occurring together with cough strongly points toward a common cold [cough · runny nose]

Signs — what you find (4)

  • Vital signs are usually normal, and any fever tends to stay low-grade [fever]
  • A high fever, tonsillitis, ear infection, or a productive cough with breathlessness suggest a complication or a different diagnosis rather than a plain cold [breathlessness · cough · fever]
  • Throat exam should check for redness, exudate, enlarged tonsils, or petechiae, and the neck for swollen nodes or thyroid masses [petechiae · redness]
  • Ears and chest should be examined to exclude otitis or lower respiratory involvement

Tests (2)

  • Most colds need no testing, since they are self-limited infections usually caused by rhinovirus or adenovirus
  • Testing for Group A strep should be considered when the clinical picture suggests bacterial throat infection

SourceStatPearls "Upper Respiratory Tract Infections With Focus on The Common Cold" - disease-level clinical article

Presentation findings are traced to the source above.

Rx: Main treatment | Pain and fever | Nasal congestion

MAIN TREATMENT - choose one, plus any add-on marked below

1

PARACETAMOL

1st line

Strength500 mg

Formoral.solid

Adult dose and duration

1 g 3 or 4 times daily (max. 4 g daily) for fever, sore throat, or body aches

Paediatric dose

10-15 mg/kg/dose [child max 500 mg]

(Child 1 month and over: 15 mg/kg 3 or 4 times daily (max. 60 mg/kg daily). Child under 1 month: 10 mg/kg 3 or 4 times daily (max. 40 mg/kg daily).)

Dose by weight
3kg30-45 mg/dose
4kg40-60 mg/dose
5kg50-75 mg/dose
6kg60-90 mg/dose
7kg70-105 mg/dose
8kg80-120 mg/dose
9kg90-135 mg/dose
10kg100-150 mg/dose
11kg110-165 mg/dose
12kg120-180 mg/dose
13kg130-195 mg/dose
14kg140-210 mg/dose
15kg150-225 mg/dose
16kg160-240 mg/dose
17kg170-255 mg/dose
18kg180-270 mg/dose
19kg190-285 mg/dose
20kg200-300 mg/dose
21kg210-315 mg/dose
22kg220-330 mg/dose
23kg230-345 mg/dose
24kg240-360 mg/dose
25kg250-375 mg/dose
26kg260-390 mg/dose
27kg270-405 mg/dose
28kg280-420 mg/dose
29kg290-435 mg/dose
30kg300-450 mg/dose
31kg310-465 mg/dose
32kg320-480 mg/dose
33kg330-495 mg/dose
34kg340-500 mg/dose (upper capped)
35kg350-500 mg/dose (upper capped)
36kg360-500 mg/dose (upper capped)
37kg370-500 mg/dose (upper capped)
38kg380-500 mg/dose (upper capped)
39kg390-500 mg/dose (upper capped)
40kg400-500 mg/dose (upper capped)
41kg410-500 mg/dose (upper capped)
42kg420-500 mg/dose (upper capped)
43kg430-500 mg/dose (upper capped)
44kg440-500 mg/dose (upper capped)
45kg450-500 mg/dose (upper capped)
46kg460-500 mg/dose (upper capped)
47kg470-500 mg/dose (upper capped)
48kg480-500 mg/dose (upper capped)
49kg490-500 mg/dose (upper capped)
50kg500 mg/dose (capped)
Dose source

MSF Essential Drugs 2024 - paracetamol (oral)

Why

First-line symptomatic antipyretic and analgesic for viral upper respiratory tract infection in adults and children

Cautions
  • Routine antibiotics are NOT indicated for uncomplicated viral upper respiratory tract infections.
  • Do not exceed max daily dose (4 g/day adult; 60 mg/kg/day paediatric) due to hepatotoxicity risk.
  • 500 mg is the per-dose ceiling used here for a child. 1000 mg is the adult dose and does not belong in a weight calculation - the daily 60 mg/kg limit is the one that binds first in any case.
Egyptian brands
Egyptian brandManufacturerIndicative price
FEBRIMOL 500 MG 20 TAB.PHARCO3.50 EGP (0.17/unit)
CETAMOL 500 MG 20 TABS.MEMPHIS8.00 EGP (0.40/unit)
PARACETAMOL-MUP 500MG B.P. 20 TABS.MUP13.00 EGP (0.65/unit)
CETAL 500 MG 20 TABS.EIPICO24.00 EGP (1.20/unit)
ARKADOLOW 500 MG 30 F.C. TABS.UTOPIA42.00 EGP (1.40/unit)
PARAMOL 500MG 20 TAB.MISR38.00 EGP (1.90/unit)
ADOL 500MG 24 CAPLETSJULPHAR32.00 EGP
AUGICETAMIDE 500 MG 20 SACHETSAUG PHARMA50.00 EGP
FEBRIMOL ORAL DROPS 20 ML? strength differs? different route - not oral solidPHARCO4.00 EGP
THERA-LO 3.2G/100ML ORAL SUSP. 100 ML? strength differs? different route - not oral solidPHAROPHARMA5.00 EGP
2

REFERRAL & SAFETY-NETTING (NO DRUG THERAPY)

1st line
Dose source

Upper Respiratory Tract Infections With Focus on The Common Cold - disease-level clinical article (common-cold-clinical.txt)

Why

Carries the referral criteria and warning signs for this condition, which apply whichever treatment is chosen.

Cautions
  • RED FLAG - Some clinical findings (high fever, pharyngitis, tonsillitis, otitis, cervical adenopathy, wheezing, productive cough, or dyspnea) add complexity and warrant further investigation for complications or an alternative diagnosis.
  • RED FLAG - Antibiotics ARE indicated for severe acute otitis media, sinusitis lasting more than 10 days, or sinus symptoms worsening after initial improvement - they are not routinely needed otherwise.
3

OXYMETAZOLINE

add-on - not a substitute

Formnasal

Adult dose and duration

0.05% (0.5 mg/mL) nasal spray: 1-2 sprays into each nostril every 12 hours. No more than 8 sprays in any 24 hours. - Do not use for more than 5 consecutive days.

Paediatric dose

(Licensed from 6 years at this 0.05% strength - not from 12. Children 6-10 years: 1 spray into each nostril every 12 hours, maximum 4 sprays in 24 hours; over 10 years, as for adults. Contraindicated under 6 years - Egypt registers separate 0.025% paediatric preparations (Iliadin paediatric, Afrin pediatric, Oxymet paed) for that age group; dose those from their own carton, no figure for them is quoted here.)

Dose by age
6 to 10 years:1 spray of the 0.05% strength into each nostril every 12 hours, maximum 4 sprays in 24 hours. Contraindicated under 6 years at this strength.
Over 10 years:As for adults.
Dose source

Afrin 0.5 mg/ml nasal spray SmPC sections 4.1-4.3 - Dutch Medicines Evaluation Board (CBG-MEB), procedure NL/H/1971/001-004, Aug 2022 (afrin-oxymetazoline-smpc-cbg-nl-2022.txt): "Afrin 0,5 mg/ml neusspray, oplossing" and "Elke ml oplossing bevat 0,5 mg oxymetazolinehydrochloride", which is the 0.05% strength.

Why

Adrenergic topical decongestant that constricts nasal venous sinuses to relieve nasal obstruction in viral upper respiratory tract infection. Two regulator documents were opened and they differ on the ceiling: the 2022 CBG SmPC caps the day at 8 sprays, while the SAHPRA Iliadin Professional Information allows two to three sprays two to three times a day. The tighter and newer figure is printed.

Cautions
  • Do not use for more than 5 consecutive days - the MHRA shortened this from 7 days on 30 April 2026 because of rebound congestion (rhinitis medicamentosa) and tachyphylaxis with overuse. The 2022 SmPC still says 7 days.
  • Not for children under 6 years at the 0.05% adult strength; use a 0.025% paediatric preparation instead.
  • Do not exceed 8 sprays in 24 hours (adults) or 4 (children).
  • Contraindicated with MAO inhibitors or within 2 weeks of stopping them, in narrow-angle glaucoma, in acute coronary disease or cardiac asthma, in rhinitis sicca, and after transsphenoidal hypophysectomy.
  • Use with care in coronary heart disease, hypertension, hyperthyroidism, diabetes, and prostatic enlargement causing difficulty passing urine.
Egyptian brands
Egyptian brandManufacturerIndicative price
NASOPHARM 0.05% SPRAYMUP > EGYPTIAN PHARMACISTS COMPANY2.50 EGP
ILIADIN 0.05 % ADULT NASAL SPRAYAMOUN > MERCK KGAA F.R.GERMANY4.30 EGP
ILIADIN 0.05 % ADULT NASAL SOLUTION 10 MLAMOUN > MERCK KGAA F.R.GERMANY3.35 EGP
OXYMET 0.05% ADULT NASAL DROPS 15 MLPHAROPHARMA15.00 EGP
ADOFRINAZ 0.05% NASAL DROPS 20 MLKAHIRA > ARAB DRUG COMPANY (ADCO)24.00 EGP
NORMIFRIN 0.5MG/ML NASAL SPRAY 20 MLMUP26.00 EGP
ILIADIN 0.025 % PAED. NASAL SOL. 10 MLAMOUN > MERCK KGAA F.R.GERMANY3.20 EGP
OXYMET 0.025% PAED.NASAL DROPS 15 MLPHAROPHARMA15.00 EGP

PAIN AND FEVER - give alongside

4

IBUPROFEN

Pain and fever

add-on - not a substitute

Strength400 mg

Formoral.solid

Adult dose and duration

200-400 mg every 6-8 hours PRN with food for fever, myalgia, or headache (max 1200 mg/day OTC)

Paediatric dose

5-6.67 mg/kg/dose [child max 400 mg]

(Every 8 hours PRN with food in infants >3 months (5-10 mg/kg/dose 3 times daily. Daily ceiling: the suspension's own label caps pain-and-fever use at 20 mg/kg/day, while the reference literature allows up to 40. Stay near 20 unless there is a reason to climb, never exceed 400 mg in a single dose, and note that 30-40 mg/kg/day is the juvenile arthritis range rather than an analgesic one.)

Dose by weight
3kg15-20 mg/dose
4kg20-26.7 mg/dose
5kg25-33.4 mg/dose
6kg30-40 mg/dose
7kg35-46.7 mg/dose
8kg40-53.4 mg/dose
9kg45-60 mg/dose
10kg50-66.7 mg/dose
11kg55-73.4 mg/dose
12kg60-80 mg/dose
13kg65-86.7 mg/dose
14kg70-93.4 mg/dose
15kg75-100 mg/dose
16kg80-106.7 mg/dose
17kg85-113.4 mg/dose
18kg90-120.1 mg/dose
19kg95-126.7 mg/dose
20kg100-133.4 mg/dose
21kg105-140.1 mg/dose
22kg110-146.7 mg/dose
23kg115-153.4 mg/dose
24kg120-160.1 mg/dose
25kg125-166.8 mg/dose
26kg130-173.4 mg/dose
27kg135-180.1 mg/dose
28kg140-186.8 mg/dose
29kg145-193.4 mg/dose
30kg150-200.1 mg/dose
31kg155-206.8 mg/dose
32kg160-213.4 mg/dose
33kg165-220.1 mg/dose
34kg170-226.8 mg/dose
35kg175-233.4 mg/dose
36kg180-240.1 mg/dose
37kg185-246.8 mg/dose
38kg190-253.5 mg/dose
39kg195-260.1 mg/dose
40kg200-266.8 mg/dose
41kg205-273.5 mg/dose
42kg210-280.1 mg/dose
43kg215-286.8 mg/dose
44kg220-293.5 mg/dose
45kg225-300.1 mg/dose
46kg230-306.8 mg/dose
47kg235-313.5 mg/dose
48kg240-320.2 mg/dose
49kg245-326.8 mg/dose
50kg250-333.5 mg/dose
Dose source

Ibuprofen 100 mg/5 ml SmPC section 4.2 (eMC product 4560)

Why

Adjunct NSAID added to supportive care for fever, myalgia, or headache in a viral cold; it treats symptoms only and does not shorten the viral illness itself.

Cautions
  • Take with food to minimize gastric irritation.
  • Avoid in active peptic ulcer disease, severe renal impairment, or NSAID-sensitive asthmatics.
  • The 400 mg per-dose ceiling comes from the reference literature, not from the suspension label - that label's largest paediatric single dose is 200 mg. Below about 40 kg the weight calculation binds first and the ceiling never comes into it.
  • Contraindicated in the last trimester of pregnancy.
Egyptian brands
Egyptian brandManufacturerIndicative price
DAJUANOFEN 400 MG 20 F.C. TABS.COPAD PHARMA5.00 EGP (0.25/unit)
FLABU 400MG 10 F.C.TAB.DELTA PHARMA3.75 EGP (0.38/unit)
NOVA-PROFEN 400MG 30 F.C. TABLETSSANOFI12.75 EGP (0.42/unit)
IBUPROFEN 400 MG 10 TAB.SEDICO6.00 EGP (0.60/unit)
MAFO 400 MG 30 F.C.TABSEIPICO42.00 EGP (1.40/unit)
BRUFEN 400 MG 30 TABS.KAHIRA > ABBOTT LABORATORIES78.00 EGP (2.60/unit)
PROFUSOL 400MG 20 S.G CAPS.EUROPEAN EGYPTIAN PHARM. IND.31.00 EGP
ANALGIPROF 400 MG 25 SACHETSEVA PHARMA37.50 EGP
NOVA-PROFEN 100MG/5ML ORAL SUSP. 100ML? strength differs? different route - not oral solidSANOFI2.25 EGP
BRUFEMOL-N SUSP. 60 ML? strength differs? different route - not oral solidARAB DRUG COMPANY (ADCO)4.50 EGP

NASAL CONGESTION - give alongside

5

SODIUM CHLORIDE

Nasal congestion

add-on - not a substitute

Formnasal

Adult dose and duration

Squeeze bottle twice in each nostril, as often as needed, or as directed by doctor.

Paediatric dose

Squeeze bottle twice in each nostril, as often as needed, or as directed by doctor.

Dose source

Saline Nasal Spray (sodium chloride 0.65%) US OTC Drug Facts (DailyMed SetID ed30a7f9-7132-42da-9bed-63a9b1c80ab2)

Why

A drug-free saline that moistens the nasal passages instead of constricting them, so it carries none of the rebound risk that comes with a true decongestant. The label covers infants directly, giving a drop-based method for them, but it does not clear the product for pregnancy on its own authority - it tells the pregnant or breastfeeding user to check with a health professional first.

Cautions
  • First choice in infants, where the label states the method directly - in the infant it is given as drops. It is not itself a decongestant: it adds moisture instead of constricting the mucosa, which is why it carries none of the rebound congestion (rhinitis medicamentosa) that follows the topical sympathomimetics.
  • Keep nasal tip clean to prevent microbial contamination.
  • The frequency here is conventional practice. The OTC label supports saline for dry and irritated nasal passages and says it is safe for frequent daily use, but prints no number of sprays and no schedule.
Egyptian brands
Egyptian brandManufacturerIndicative price
SALINE 7.4MG/ML NASAL DROPS 15 MLPHARCO > EUROPEAN EGYPTIAN PHARM. IND.3.25 EGP
SODIUM CHLORIDE 0.9 % (EL NILE) I.V. INF. 100 ML (RUBBER CAP)EL NILE.4.75 EGP
SODIUM CHLORIDE 0.9% (OTSUKA) IRRIGATION SOLN. 1000 MLOTSUKA12.00 EGP
SODIUM CHLORIDE 0.9% (EL NASR) IRRIGAATION SOLN. 3000 MLEL NASR22.50 EGP
FREE NOSE NASAL SPRAY 30 ML (6+ YEARS)PHARMALINK S.L. > AUG PHARMA75.00 EGP
SOFIMER 0.9% ISOTONIC NASAL SPRAY 100 ML> SOFICOPHARM290.00 EGP
MARIMER ISOTONIC NASAL SPRAY 100MLLABORATOIRES GILBERT - FRANCE > UNITED BIONAT385.00 EGP
PHYSIOMER BABY MIST NASAL SPRAY 115MLLABORATOIRE DE LA MER > STAR INTERNATIONAL COMPANY400.00 EGP

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.